 |
|
 |
Rheumatology (Oxford). 2005 Sep 7; [Epub ahead of print] Related
Articles, Links
Contrasting effects of fluoroquinolone antibiotics on the expression
of the collagenases, matrix metalloproteinases (MMP)-1 and -13, in
human tendon-derived cells.
Corps AN, Harrall RL, Curry VA, Hazleman BL, Riley GP.
Rheumatology Research Unit, Box 194, Addenbrooke's Hospital, Hills
Road, Cambridge CB2 2QQ, UK.
Objectives. Fluoroquinolone antibiotics may cause tendon pain and
rupture. We reported previously that the fluoroquinolone ciprofloxacin
potentiated interleukin (IL)-1beta-stimulated expression of matrix
metalloproteinases (MMP)-3 and MMP-1 in human tendon-derived cells. We
have now tested additional fluoroquinolones and investigated whether
they have a similar effect on expression of MMP-13. Methods. Tendon
cells were incubated for two periods of 48 h with or without
fluoroquinolones and IL-1beta. Total ribonucleic acid (RNA) was
assayed for MMP messenger RNA by relative quantitative reverse
transcriptase polymerase chain reaction, with normalization for
glyceraldehyde-3-phosphate dehydrogenase mRNA. Samples of supernatant
medium were assayed for MMP output by activity assays. Results. MMP-13
was expressed by tendon cells at lower levels than MMP-1, and was
stimulated typically 10- to 100-fold by IL-1beta. Ciprofloxacin,
norfloxacin and ofloxacin each reduced both basal and stimulated
expression of MMP-13 mRNA. In contrast, ciprofloxacin and norfloxacin
increased basal and IL-1beta-stimulated MMP-1 mRNA expression. Both
the inhibition of MMP-13 and the potentiation of MMP-1 expression by
fluoroquinolones were accompanied by corresponding changes in
IL-1beta-stimulated MMP output. The non-fluorinated quinolone
nalidixic acid had lesser or no effects. Conclusions. Fluoroquinolones
show contrasting effects on the expression of the two collagenases
MMP-1 and MMP-13, indicating specific effects on MMP gene regulation.
|
 |